ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.49545
0.13%
Brent Oil
81.985
-0.17%
Bitcoin
66,325.98
-0.47%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Biostar Pharmaceuticals Inc (CE) (BSPM)

  7. Biostar Pharmaceuticals Inc (CE) (BSPM) Noticias

BSPM

Biostar Pharmaceuticals (CE) (BSPM)

Biostar Pharmaceuticals Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:BSPM
FechaHoraFuenteTítuloSímboloCompañía
08/01/201909:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/08/201808:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/08/201807:51GlobeNewswire Inc.Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from NasdaqUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/07/201816:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
16/05/201815:12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/04/201815:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/02/201815:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/11/201715:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201715:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/04/201715:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/01/201705:02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/01/201715:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
30/12/201615:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/10/201615:26Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
12/10/201615:46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/07/201407:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
11/01/201315:34Edgar (US Regulatory)Current report filing (8-K)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/11/201206:33Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201207:03Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/09/201215:31Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/04/201216:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
27/03/201206:34Edgar (US Regulatory)Annual Report (10-K)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/12/201115:55Edgar (US Regulatory)Amended Current report filing (8-K/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/06/201113:39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/05/201109:08Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
05/04/201108:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/03/201105:50GlobeNewswire Inc.Biostar Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
29/12/201008:58Edgar (US Regulatory)Statement of Ownership (SC 13G)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201007:45Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/02/201000:30GlobeNewswire Inc.EquityNet Research Initiates Independent Research Coverage on Biostar Pharmaceuticals, Inc.USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:BSPM

Su Consulta Reciente

COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
CCOM
OILBRENT
Brent Oil
CCOM
US30
US 30
FX
USDMXN
US Dollar vs MXN
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados